Fundraising Fox
/Companies
Sign in

Output Biosciences

YC S21

New York City, US · Founded 2021 · 8 employees · Hiring · 14 known investors

Find your way into Output Biosciences

Sign up to find every way you can get introduced to Output Biosciences

  • Your email: who you already know at Output Biosciences, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Output Biosciences team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Output builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.

Also known as Jingu Health

AI & Machine LearningBiotechHealthtechMedical DevicesAI-powered Drug DiscoveryGenerative AIAIUnited States of AmericaAmerica / Canada

Investors · 14

Great Oaks Venture Capitallisted by Great Oaks Venture CapitalNew York · $50K – $500K

How we know: Great Oaks Venture Capital's portfolio page · Not right? Tell us

Icebook Investments Corp.listed by Icebook Investments Corp.Calgary

How we know: Icebook Investments Corp.'s portfolio page · Y Combinator's founder network · Not right? Tell us

Olive Tree Capitallisted by Olive Tree CapitalBoston

How we know: Olive Tree Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · Not right? Tell us

Calibrate VenturesreportedPasadena · $5M

How we know: Y Combinator's founder network · Not right? Tell us

First Round CapitalreportedSan Francisco · $100K – $20M

How we know: Y Combinator's founder network · Not right? Tell us

FrialereportedNashville · $100K – $600K

How we know: Y Combinator's founder network · Not right? Tell us

Green Cow Venture CapitalreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Hustle FundreportedSan Carlos · $150K

How we know: Y Combinator's founder network · Not right? Tell us

ImmeasurablereportedLos Angeles · $25K – $100K

How we know: Y Combinator's founder network · Not right? Tell us

Julian Shapiroreported

How we know: Y Combinator's founder network · Not right? Tell us

Lerer HippeaureportedNew York · $500K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Mesia Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

Actio Biosciences, Inc.Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
WonderTxWonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.
Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
Ångström AIÅngström AI develops AI-powered physics simulations for pharmaceutical drug discovery, computing molecular properties like solubility, lipophilicity, and crystal structure stability to replace traditional lab experiments. The platform uses machine learning interatomic potentials and free energy calculations to accelerate and derisk solid form development for pharma companies.
Generate BiomedicinesGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
Rosebud BiosciencesRosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.
Ditto BiosciencesDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
AviadoBioAviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). It is a spinout from King's College London research focused on the genetics and molecular biology of these diseases.
Recursion PharmaceuticalsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.

Companies working in the same space as Output Biosciences.

Frequently asked questions

What does Output Biosciences do?
Output builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.
Who are Output Biosciences's investors?
Output Biosciences's investors include Able Partners, Great Oaks Venture Capital, Icebook Investments Corp., Olive Tree Capital, Y Combinator, Calibrate Ventures, First Round Capital, Friale and 6 more.
Where is Output Biosciences headquartered?
Output Biosciences is headquartered in New York City, US.